BRISTOL-MYERS SQUIBB CO (BMY:NYSE)
$62.56 0.47 (0.757%)
Analysed BRISTOL-MYERS SQUIBB CO (BMY:NYSE) News Sources
3 Healthcare Stocks We Keep Off Our Radar
24-07-2026
yahoo.com
Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer
24-07-2026
fool.com
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test
25-07-2026
yahoo.com
Israel "Izzy" Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn't?
26-07-2026
fool.com
Wall Street's Insights Into Key Metrics Ahead of Bristol Myers (BMY) Q2 Earnings
27-07-2026
yahoo.com
Immunocore's Kimmtrak Growth Story and Major 2026 Catalysts Ahead
27-07-2026
yahoo.com
Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth?
27-07-2026
yahoo.com
How Immunocore Is Expanding Beyond Its Rare-Cancer Drug Kimmtrak
27-07-2026
yahoo.com
Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?
27-07-2026
yahoo.com
The Engine Behind ABBV Stock Has Real Parts
27-07-2026
trefis.com
What is the current price of BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The current price of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is $62.56.
BRISTOL-MYERS SQUIBB CO (BMY:NYSE) absolute price change since previous trading day?
The absolute price change of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) since the previous trading day is $0.47.
BRISTOL-MYERS SQUIBB CO (BMY:NYSE) percentage price change since previous trading day?
The percentage price change of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) since the previous trading day is 0.757%.
What is the most recent average sentiment score for BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The most recent average sentiment score for BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is 64 out of 100.
What is the most recent average sentiment for BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The most recent sentiment for BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is .
SEC-8K** Filing Available For BRISTOL-MYERS SQUIBB CO (BMY:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.